Charon Spencer Email

Chief Human Resources Officer . Ardelyx

Fremont, CA

Location

LinkedIn

Current Roles

Employees:
340
Revenue:
$24.6M
About
Ardelyx is focused on enhancing the way people with kidney and cardiovascular diseases are treated by developing innovative first-in-class medicines. Ardelyx's pipeline includes tenapanor for the control of serum phosphorus in adult patients with CKD on dialysis, for which the Company is preparing for NDA filing mid-year, and RDX013, a potassium secretagogue program for the potential treatment of high potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease. In addition, Ardelyx received FDA approval of IBSRELAᅢᆵᅥメᅡᄁ (tenapanor) on September 12, 2019. Ardelyx has established agreements with Kyowa Kirin Corporation in Japan, Fosun Pharma in China and Knight Therapeutics in Canada for the development and commercialization of tenapanor in the respective territories. For more information, please visit http://www.ardelyx.com/ and connect with us on Twitter @Ardelyx.
Ardelyx Address
34175 Ardenwood Boulevard
Fremont, CA
United States
Ardelyx Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.